Skip to content
Clinical Trials – home

Migraine with aura

  • 8 clinical trials
Quick filters

8 Clinical trials

Migraine+2

Recruiting

Study on the Long-Term Safety of Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Migraine+2

Recruiting

Study on Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

Registered drug
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Migraine+2

Recruiting

Study on the Safety and Effectiveness of Atogepant for Preventing Episodic Migraine in Children and Teens Aged 6 to 17

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Migraine+2

Recruiting

Study on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study of amiloride tablets for prevention of migraine with aura attacks

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amiloride Hydrochloride Dihydrate
  • Sponsor:Centre Hospitalier Universitaire De Nice

Migraine+2

Not recruiting

Study on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
See all trials →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.